Form 4: Vita Coco CEO Martin Roper Sells Shares Under 10b5-1 Trading Plan

Vita Coco Company CEO Martin Roper executed multiple sales of common stock on November 6th and 7th, 2024, under a pre-arranged Rule 10b5-1 trading plan.

Summary

• Martin Roper, CEO of Vita Coco Company, sold shares of common stock on November 6th and 7th, 2024.
• The sales were executed under a Rule 10b5-1 trading plan.
• On November 6th, 2024, 5,000 shares were sold at a weighted average price of $35.419, with prices ranging from $35.07 to $35.79.
• On November 7th, 2024, 5,000 shares were sold at a weighted average price of $35.153, with prices ranging from $35.00 to $35.44.
• Additional sales of 5,000 shares each were made on both days through family trusts (Chris Roper FT, Peter Roper FT, and Thomas Roper FT) at similar weighted average prices.
• Following these transactions, Martin Roper directly owns 462,452 shares and indirectly owns shares through family trusts and his spouse.
• Roper also holds non-qualified stock options to purchase a significant number of shares at various exercise prices and vesting schedules.

Sentiment

Score: 5

Explanation: The document is neutral. It simply reports stock sales under a pre-existing plan. There is no inherent positive or negative sentiment.

Industry Context

Executive stock sales are a common occurrence, and sales under 10b5-1 plans are generally viewed as less impactful since they are pre-arranged. Investors often monitor these sales for insights into management's perspective on the company's valuation and future prospects. It is important to note that the CEO still holds a significant amount of shares and options.

Comparison to Industry Standards

• Comparing Roper's sales to other beverage industry CEOs is difficult without knowing the specific details of their compensation packages and stock ownership.
• However, it's common for CEOs of publicly traded companies like Coca-Cola (KO) or PepsiCo (PEP) to have similar arrangements for stock options and pre-planned sales.
• The size of the sale (30,000 shares) is relatively small compared to the total outstanding shares of Vita Coco, suggesting it's unlikely to have a significant impact on the stock price.

Stakeholder Impact

• The stock sales could have a minor negative impact on shareholder sentiment, although the existence of a 10b5-1 plan mitigates this.
• The sales do not directly impact employees, customers, suppliers, or creditors.

Key Dates